Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
The goal is not just weight loss, but creating a sustainable path toward long-term wellness and lasting results
Drug interactions Berberine may inhibit several cytochrome P450 enzymes (including CYP3A4, CYP2D6, and CYP2C9) and P-glycoprotein, potentially affecting the metabolism of numerous medications including statins, anticoagulants, antihypertensives, and immunosuppressants
Abstract Type 2 diabetes represents a growing challenge for global public health
Reconstitution charts by vial size Every dosing calculation starts with reconstitution